Cynajapogenin A

Details

Top
Internal ID 673219be-93b7-4a5b-abd8-6369c97c7c89
Taxonomy Benzenoids > Phenanthrenes and derivatives > Hydrophenanthrenes
IUPAC Name (2R,4aS,4bR,6R,7R,10aR)-6,7-dihydroxy-4b-methyl-2-(2-methylfuran-3-yl)-2,3,4,4a,5,6,7,8,10,10a-decahydrophenanthren-1-one
SMILES (Canonical) CC1=C(C=CO1)C2CCC3C(C2=O)CC=C4C3(CC(C(C4)O)O)C
SMILES (Isomeric) CC1=C(C=CO1)[C@H]2CC[C@H]3[C@H](C2=O)CC=C4[C@@]3(C[C@H]([C@@H](C4)O)O)C
InChI InChI=1S/C20H26O4/c1-11-13(7-8-24-11)14-5-6-16-15(19(14)23)4-3-12-9-17(21)18(22)10-20(12,16)2/h3,7-8,14-18,21-22H,4-6,9-10H2,1-2H3/t14-,15-,16+,17-,18-,20+/m1/s1
InChI Key XJPLSDCQIUZBTE-QEYSWXTQSA-N
Popularity 0 references in papers

Physical and Chemical Properties

Top
Molecular Formula C20H26O4
Molecular Weight 330.40 g/mol
Exact Mass 330.18310931 g/mol
Topological Polar Surface Area (TPSA) 70.70 Ų
XlogP 2.20
Atomic LogP (AlogP) 3.12
H-Bond Acceptor 4
H-Bond Donor 2
Rotatable Bonds 1

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of Cynajapogenin A

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9969 99.69%
Caco-2 + 0.5236 52.36%
Blood Brain Barrier + 0.5105 51.05%
Human oral bioavailability - 0.5286 52.86%
Subcellular localzation Mitochondria 0.8168 81.68%
OATP2B1 inhibitior - 1.0000 100.00%
OATP1B1 inhibitior + 0.9126 91.26%
OATP1B3 inhibitior + 0.9678 96.78%
MATE1 inhibitior - 0.9400 94.00%
OCT2 inhibitior - 0.7787 77.87%
BSEP inhibitior - 0.4786 47.86%
P-glycoprotein inhibitior - 0.7745 77.45%
P-glycoprotein substrate - 0.6843 68.43%
CYP3A4 substrate + 0.6924 69.24%
CYP2C9 substrate - 0.8155 81.55%
CYP2D6 substrate - 0.7488 74.88%
CYP3A4 inhibition - 0.5573 55.73%
CYP2C9 inhibition - 0.8083 80.83%
CYP2C19 inhibition - 0.7664 76.64%
CYP2D6 inhibition - 0.8818 88.18%
CYP1A2 inhibition - 0.5688 56.88%
CYP2C8 inhibition + 0.5830 58.30%
CYP inhibitory promiscuity - 0.8042 80.42%
UGT catelyzed + 0.8000 80.00%
Carcinogenicity (binary) - 0.8900 89.00%
Carcinogenicity (trinary) Non-required 0.4819 48.19%
Eye corrosion - 0.9920 99.20%
Eye irritation - 0.9929 99.29%
Skin irritation - 0.5932 59.32%
Skin corrosion - 0.9309 93.09%
Ames mutagenesis - 0.6600 66.00%
Human Ether-a-go-go-Related Gene inhibition - 0.4033 40.33%
Micronuclear - 0.7900 79.00%
Hepatotoxicity + 0.5875 58.75%
skin sensitisation - 0.8076 80.76%
Respiratory toxicity + 0.7222 72.22%
Reproductive toxicity + 0.9556 95.56%
Mitochondrial toxicity + 0.9000 90.00%
Nephrotoxicity + 0.6447 64.47%
Acute Oral Toxicity (c) IV 0.3973 39.73%
Estrogen receptor binding + 0.8627 86.27%
Androgen receptor binding + 0.7076 70.76%
Thyroid receptor binding + 0.5749 57.49%
Glucocorticoid receptor binding + 0.7929 79.29%
Aromatase binding + 0.6562 65.62%
PPAR gamma - 0.6264 62.64%
Honey bee toxicity - 0.8169 81.69%
Biodegradation - 0.8250 82.50%
Crustacea aquatic toxicity + 0.6400 64.00%
Fish aquatic toxicity + 0.9960 99.60%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL4261 Q16665 Hypoxia-inducible factor 1 alpha 97.26% 85.14%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 96.26% 91.11%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 92.86% 96.09%
CHEMBL3137262 O60341 LSD1/CoREST complex 91.51% 97.09%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 91.25% 95.56%
CHEMBL1806 P11388 DNA topoisomerase II alpha 90.69% 89.00%
CHEMBL1994 P08235 Mineralocorticoid receptor 90.19% 100.00%
CHEMBL5608 Q16288 NT-3 growth factor receptor 86.35% 95.89%
CHEMBL3038477 P67870 Casein kinase II alpha/beta 84.64% 99.23%
CHEMBL2581 P07339 Cathepsin D 84.50% 98.95%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 83.43% 94.45%
CHEMBL221 P23219 Cyclooxygenase-1 80.62% 90.17%
CHEMBL226 P30542 Adenosine A1 receptor 80.29% 95.93%

Cross-Links

Top
PubChem 15378970
NPASS NPC62559
LOTUS LTS0104910
wikiData Q105002612